Therapeutic potential of nanotechnology in reproduction disorders and possible limitations

P.A.A. Barroso, Pedro Alves Aguiar Barroso, Danisvânia Ripardo Nascimento, Miguel F De Lima Neto, Ernando Igo T De Assis, Ernando Igo Teixeira de Assis, Ciro Siqueira Figueira, José Roberto Viana Silva
Zygote (Cambridge, England) · 2023 · vol. 31(5) , pp. 433–440 · doi:10.1017/s0967199423000424 · PMID:37537957 · W4385564274
review OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

One of the prominent peculiarities of nanoparticles (NPs) is their ability to cross biological barriers. Therefore, the development of NPs with different properties has great therapeutic potential in the area of reproduction because the association of drugs, hormones and other compounds with NPs represents an alternative for delivering substances directly at a specific site and for treatment of reproductive problems. Additionally, lipid-based NPs can be taken up by the tissues of patients with ovarian failure, deep endometriosis, testicular dysfunctions, etc., opening up new perspectives for the treatment of these diseases. The development of nanomaterials with specific size, shape, ligand density and charge certainly will contribute to the next generation of therapies to solve fertility problems in humans. Therefore, this review discusses the potential of NPs to treat reproductive disorders, as well as to regulate the levels of the associated hormones. The possible limitations of the clinical use of NPs are also highlighted.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Nanotechnology Reproduction Reproduction

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (98)

Source provenance

europepmc
last seen: 2026-06-16T06:07:01.518242+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-06-16T06:05:51.128802+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK